416 related articles for article (PubMed ID: 1383404)
1. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
[TBL] [Abstract][Full Text] [Related]
2. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
[TBL] [Abstract][Full Text] [Related]
3. Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.
Taylor G; Stott EJ; Furze J; Ford J; Sopp P
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2217-23. PubMed ID: 1383403
[TBL] [Abstract][Full Text] [Related]
4. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.
Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297
[TBL] [Abstract][Full Text] [Related]
5. Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.
Bourgeois C; Corvaisier C; Bour JB; Kohli E; Pothier P
J Gen Virol; 1991 May; 72 ( Pt 5)():1051-8. PubMed ID: 2033389
[TBL] [Abstract][Full Text] [Related]
6. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants.
Martínez I; Dopazo J; Melero JA
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2419-29. PubMed ID: 9349460
[TBL] [Abstract][Full Text] [Related]
7. Location of the epitope recognized by monoclonal antibody 63G on the primary structure of human respiratory syncytial virus G glycoprotein and the ability of synthetic peptides containing this epitope to induce neutralizing antibodies.
Garcia-Barreno B; Delgado T; Akerlind-Stopner B; Norrby E; Melero JA
J Gen Virol; 1992 Oct; 73 ( Pt 10)():2625-30. PubMed ID: 1383397
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.
Trudel M; Stott EJ; Taylor G; Oth D; Mercier G; Nadon F; Séguin C; Simard C; Lacroix M
Arch Virol; 1991; 117(1-2):59-71. PubMed ID: 1706591
[TBL] [Abstract][Full Text] [Related]
9. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.
García-Barreno B; Palomo C; Peñas C; Delgado T; Perez-Breña P; Melero JA
J Virol; 1989 Feb; 63(2):925-32. PubMed ID: 2463385
[TBL] [Abstract][Full Text] [Related]
10. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
Anderson K; Stott EJ; Wertz GW
J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280
[TBL] [Abstract][Full Text] [Related]
11. Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus.
López JA; Peñas C; García-Barreno B; Melero JA; Portela A
J Virol; 1990 Feb; 64(2):927-30. PubMed ID: 1688629
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
Orvell C; Norrby E; Mufson MA
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
[TBL] [Abstract][Full Text] [Related]
13. Antigenic structure of human respiratory syncytial virus fusion glycoprotein.
López JA; Bustos R; Orvell C; Berois M; Arbiza J; García-Barreno B; Melero JA
J Virol; 1998 Aug; 72(8):6922-8. PubMed ID: 9658147
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.
Walsh EE; Hall CB; Schlesinger JJ; Brandriss MW; Hildreth S; Paradiso P
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2953-61. PubMed ID: 2479715
[TBL] [Abstract][Full Text] [Related]
15. Antigenic structure of the fusion glycoprotein of respiratory syncytial virus.
Paradiso PR; Hu B; Hildreth S; Martin A; Arumugham R
Adv Exp Med Biol; 1989; 251():273-8. PubMed ID: 2481965
[No Abstract] [Full Text] [Related]
16. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein.
Crowe JE; Firestone CY; Crim R; Beeler JA; Coelingh KL; Barbas CF; Burton DR; Chanock RM; Murphy BR
Virology; 1998 Dec; 252(2):373-5. PubMed ID: 9878616
[TBL] [Abstract][Full Text] [Related]
17. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
Marsh R; Connor A; Gias E; Toms GL
J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
[TBL] [Abstract][Full Text] [Related]
18. Epitope specificities of human serum antibodies reactive with respiratory syncytial virus fusion protein.
Robinson BS; Everson JS
Arch Virol; 1992; 125(1-4):273-86. PubMed ID: 1379425
[TBL] [Abstract][Full Text] [Related]
19. Mapping of monoclonal antibody epitopes of the human respiratory syncytial virus p protein.
García J; García-Barreno B; Martinez I; Melero JA
Virology; 1993 Jul; 195(1):239-42. PubMed ID: 7686311
[TBL] [Abstract][Full Text] [Related]
20. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.
Murphy BR; Walsh EE
J Clin Microbiol; 1988 Aug; 26(8):1595-7. PubMed ID: 2459154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
